CHJ.99595
Methotrexate
--
--
Ordering
Available Variants25 mg
CHJ.99595-25mg
Price
€182.40
Available – Dispatch in 14 days
100 mg
CHJ.99595-100mg
Price
€483.20
Available – Dispatch in 14 days
250 mg
CHJ.99595-250mg
Price
€113.60
Available – Dispatch in 14 days
1 g
CHJ.99595-1g
Price
€342.40
Available – Dispatch in 14 days
5 g
CHJ.99595-5g
Price
€668.00
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHJ.99595-25mg | €182.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHJ.99595-100mg | €483.20 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
250 mg | CHJ.99595-250mg | €113.60 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
1 g | CHJ.99595-1g | €342.40 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 g | CHJ.99595-5g | €668.00 |
meets USP testing specifications
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C20H22N8O5 · xH2O |
|---|---|
| CAS Number | 133073-73-1 |
| Molecular Weight | 454.44 (anhydrous basis) |
| NACRES | NA.21 |
| PubChem Substance ID | 24897373 |
| UNSPSC Code | 12352005 |
| MDL number | MFCD00150847 |
Safety Information Handling visibility
| pictograms |
GHS06
GHS08
 GHS06,GHS08
|
|---|---|
| signalword | Danger |
| hcodes | H301,H315,H319,H360FD |
| pcodes | P202 - P264 - P280 - P301 + P310 - P302 + P352 - P305 + P351 + P338 |
| Hazard Classifications | Acute Tox. 3 Oral - Eye Irrit. 2 - Repr. 1B - Skin Irrit. 2 |
| Storage Class | 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
| ppe | Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges |
Technical Overview & Applications Use-case context
Methotrexate, with a Chemical Abstracts Service (CAS) number of 59-05-2, is a chemotherapeutic agent and immune system suppressant. It is commonly used to treat various types of cancer, including breast, lung, and blood cancers, as well as autoimmune diseases such as rheumatoid arthritis and psoriasis. Methotrexate functions by inhibiting the metabolism of folic acid, which is necessary for the production of DNA and cell replication. As a result, it can effectively slow down or stop the growth of rapidly dividing cells, such as cancer cells and immune cells. However, due to its potential toxicity, methotrexate requires careful dosing and monitoring to minimize side effects, which can include gastrointestinal issues, bone marrow suppression, and liver damage, highlighting the need for close medical supervision during treatment. Its mechanism of action and therapeutic applications have been extensively studied.
